The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Scrip dividend reference price

18 Jul 2019 14:29

RNS Number : 0198G
Primary Health Properties PLC
18 July 2019
 

 

 

Primary Health Properties PLC

(the "Company")

 

Scrip Dividend Scheme

 

The Company announces that the scrip dividend reference price for the Third Quarterly Interim Dividend in 2019 (the "Interim Dividend"), payable on 23 August 2019, is 136.72.

 

The reference price is the price at which Primary Health Properties PLC ordinary shares of 12.5p each ("Ordinary shares") will be issued to shareholders who have elected to receive shares in lieu of cash dividends through participation in the Scrip Dividend Scheme and is the average of the closing middle market quotations of the Ordinary shares derived from the London Stock Exchange Daily Official List for the day on which the Ordinary shares were first quoted as ex-dividend (11 July 2019) and the four subsequent dealing days (being 12,15,16 and 17 July 2019).

 

Shareholders, who received their holding of Ordinary Shares pursuant to the scheme of arrangement (the "Scheme") sanctioned by the Royal Court of Guernsey on 14 March 2019 (the "Scheme Effective Date"), are reminded that under the terms of the Scheme any scrip dividend mandates in force on the Scheme Effective Date in respect of their holding of ordinary shares of no par value in the MedicX Fund Limited ("MedicX Shares") shall, unless subsequently revoked or amended, be deemed valid and effective mandates in respect of their holdings of Ordinary Shares, and accordingly they need take no further action if they wish to elect for the scrip dividend alternative in respect of the Company's second interim dividend.

 

Any shareholders entitled to the Interim Dividend who do not already participate in the Scrip Dividend Scheme (or whose mandates are not deemed valid and effective, as explained above) and wish to do so, may obtain a mandate form either by contacting the Company's Registrar, Equiniti, on 0871 384 2268, or by downloading from the Company's website www.phpgroup.co.uk/Investors, or from the National Storage Mechanism. This form must be completed and returned to Equiniti to arrive no later than the close of business on 9 August 2019 in order for it to be effective for the Interim Dividend.

 

 

Contacts:

 

Paul Wright, for Nexus Management Services Limited, Secretary

Telephone: 020 7451 7050

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVUWUORKVABAAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.